MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Posturography as an objective measure of disease progression and prognostication in Progressive Supranuclear Palsy

    G. Nuebling, S. Katzdobler, J. Levin, G. Höglinger, S. Lorenzl (Munich, Germany)

    Objective: To determine the usefulness of posturography as an objective measure of disease progression and prognostication on Progressive Supranuclear Palsy (PSP). Background: To date, interventional…
  • 2023 International Congress

    Novel CACNA1A splice site variant associated with cerebellar ataxia and mild cognitive impairment; case report of Czech family.

    A. Afifi, M. Nevrly, Z. Musova, P. Hedvicakova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To describe a case of two related individuals with cerebellar ataxia with a novel variant in the calcium voltage-gated channel subunit alpha1-A (CACNA1A) gene.…
  • 2023 International Congress

    Cholinergic subtyping in Parkinson disease: differential 2-year interval changes

    N. Bohnen, S. Roytman, T. Brown, K. Frey, P. Scott, R. Koeppe, R. Albin, P. Kanel (Ann Arbor, USA)

    Objective: To investigate 2-yr interval change in cholinergic transporters in biology-based cholinergic subgroups using serial VAChT [18F]FEOBV brain PET in Parkinson’s disease (PD). Background: Current…
  • 2023 International Congress

    Chorea improvements over time with once-daily valbenazine treatment in adults with Huntington disease

    E. Furr Stimming, E. Kayson, J. Goldstein, H. Zhang, O. Klepitskaya, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To describe the effects of valbenazine (VBZ) over time on chorea in adults with Huntington disease (HD). Background: The Ph3 KINECTTM-HD (NCT04102579) trial met…
  • 2023 International Congress

    Spectrum of Hereditary Spastic Paraparesis (HSP): A study from India

    AK. Srivastava, A. Agarwal, F. Mohammad, D. Mr, A. Sonakar, R. Rajan, P. Sharma, S. Zahra, T. de, M. Fatima, S. Bari (New Delhi, India)

    Objective: To explore the genetic spectrum of hereditary spastic paraparesis in Indian patients. Background: HSP belongs to a heterogenous group of monogenic neurological disorders with…
  • 2023 International Congress

    Pre-surgical correlates of QoL (PDQ-39) in a DBS eligible PD population

    J. Jimenez-Shahed, A. Berg, J. Kirk, M. York, J. Schwalb, M. Siddiqui, J. Mcinerney (New York, USA)

    Objective: To investigate the pre-surgical correlates of quality of life (QoL) in patients with Parkinson's disease (PD) eligible for deep brain stimulation (DBS). Background: Optimizing…
  • 2023 International Congress

    Ultra long-term outcome of deep brain stimulation (DBS) compared to botulinum toxin (BoNT) treatment in cervical dystonia (CD)

    IM. Wedding, V. Siewers, IM. Skogseid (Oslo, Norway)

    Objective: To compare residual symptoms and disease-specific quality of life (DS-QoL) in CD patients treated with DBS, or BoNT injections alone, for minimum 3 years.…
  • 2023 International Congress

    Motor phenotype and disease burden among Parkinson’s disease patients of Addis Ababa, Ethiopia.

    B. Getahun, H. Demissie, H. Nuri, S. Gugssa (Dire Dawa, Ethiopia)

    Objective: This study aims to characterize the motor phenotype of Parkinson’s disease (PD), compare disease severity and to determine quality of life among the different…
  • 2023 International Congress

    Hemidystonia of cerebellar origin

    L. Costa, J. Pinto, C. Machado, I. Amorim (Viana do Castelo, Portugal)

    Objective: To report the case of a patient developing hemidystonia in the course of cerebellar hemorrhage. Background: About 1-4% of strokes may include movement disorders,…
  • 2023 International Congress

    The efficacy of dopamine agonists or monoamine oxidase type B inhibitors as monotherapy in patients with early Parkinson disease: A network meta-analysis

    CSC. Chuang (Changhua, Taiwan)

    Objective: This study aimed to investigate the effectiveness of dopamine agonists or monoamine oxidase type B inhibitors (MAOB-I) as monotherapy in patients with early Parkinson's…
  • « Previous Page
  • 1
  • …
  • 312
  • 313
  • 314
  • 315
  • 316
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley